What Is QLTY? GMO U.S. Quality ETF
Last updated September 2026
Short answer
QLTY is GMO U.S. Quality ETF, an ETF that tracks Actively managed, no tracked index at a 0.50% expense ratio. QLTY is GMO's US quality equity strategy in exchange traded form, launched in 2023. It holds a concentrated portfolio of companies the manager judges to earn high returns on capital with durable competitive positions and modest financial leverage. The ten largest positions account for around 46% of assets, an unusual level of concentration for something categorised as large blend. Technology is 40% of the fund and healthcare 23%. It charges 0.50%, which is high for an ETF and low for GMO's institutional lineage, and yields 0.88%.
QLTY is issued by GMO and tracks Actively managed, no tracked index. It charges a 0.50% expense ratio, holds approximately $4.7B in assets under management, yields about 0.88%, and launched in 2023.
A quality portfolio that starts with semiconductor equipment
The first thing that stands out is the ordering. Lam Research is the largest holding at 6.4%, ahead of Microsoft at 5.9% and Alphabet at 5.3%. KLA is fourth at 4.7%. Together those two semiconductor equipment makers are 11.1% of the fund, which is a striking allocation for a strategy built around business durability.
The logic is that semiconductor capital equipment is one of the most concentrated industries in existence. A small number of firms supply tools that chipmakers cannot easily source elsewhere, and that position generates very high returns on invested capital. Judged on economics rather than on volatility, the industry scores well on quality measures.
It also carries a specific vulnerability that a quality label can obscure. Equipment orders arrive in cycles tied to capital spending decisions by a handful of customers, and those decisions can pause abruptly. A fund with 11.1% in two equipment suppliers is exposed to that cycle regardless of how good the underlying businesses are.
Concentration is the strategy, not a side effect
Adding the ten largest positions gives roughly 46% of the fund. Beyond the semiconductor names, the list runs Apple at 4.5%, Johnson and Johnson at 4.4%, Texas Instruments at 4.1%, Broadcom at 3.9%, Meta at 3.8% and Amazon at 3.4%. There is no long tail carrying meaningful weight.
Healthcare at 23% is the second largest sector, well above what a broad US index carries, and Johnson and Johnson's 4.4% position anchors it. Communication services is 11%, financials 8% and consumer discretionary 7%. The absence of large weights in energy, utilities, real estate and materials follows from the method: those industries rarely produce the sustained high returns on capital the strategy looks for.
This is what an active manager with conviction produces, and it means results will diverge from the index for extended periods in both directions. Anyone expecting an index-like experience with a quality tilt has misjudged the product. The portfolio is small enough that individual company outcomes matter.
Fee, history and fit
At 0.50%, QLTY is expensive by ETF standards and inexpensive by the standards of the institutional asset manager running it. The comparison that matters depends on the alternative you would otherwise choose. Rules-based quality factor ETFs cost a fraction of this and apply a mechanical screen across a much wider portfolio. QLTY is charging for judgement, and judgement is only worth paying for if it turns out to be good.
The ETF dates from 2023, so its own record is short. GMO has run quality-focused equity strategies in other vehicles for considerably longer, which informs the approach, but this vehicle has not operated through a full cycle and has never held its current concentrated technology and healthcare portfolio through a serious downturn.
The 0.88% yield is incidental. Companies earning high returns on capital typically reinvest rather than distribute, and several large holdings pay little. QLTY makes sense as a concentrated core or near-core US equity position for someone comfortable with a manager making real decisions, and it makes little sense for an investor who will be unsettled by extended periods of divergence from the broad market, which concentration guarantees.
QLTY holdings: top 10
Approximate weights as of August 2026. Each ticker links to its individual stock guide in Walnut.
How do I invest in QLTY?
There are three common ways to get QLTY exposure. Buy shares (or fractional shares) of QLTY directly at any major broker that lists it. Hold it as a core position and layer more concentrated ideas on top. Or build it into a thematic portfolio in Walnut, so QLTY sits alongside other holdings that express the same thesis, with target weights you can rebalance toward. QLTY trades like a stock during market hours, so you buy it the same way you would any listed share.
New to buying funds? See how to buy an ETF, step by step.
Is QLTY a good buy?
Whether QLTY is a good buy depends less on any single call and more on your time horizon and what you already hold: it tracks Actively managed, no tracked index, so the real question is whether you want that exposure in your mix and at what weight. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is QLTY a buy?
The bottom line on QLTY
QLTY gives you Actively managed, no tracked index exposure in one ticker at a 0.50% expense ratio. Most investors use it as a core holding and layer more concentrated thematic portfolios on top.
More on QLTY
Whether QLTY is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is QLTY a buy?
QLTY yields 0.88% as of August 2026, paid by passing through the dividends of its underlying holdings. For the payout schedule, history, and how the distributions are taxed, see QLTY dividend: yield and schedule.
New to funds like QLTY? Start with what an ETF is, then how to buy an ETF, or browse the full guide to ETF investing.
Wondering how QLTY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in QLTY with AI
Connect the broker you already use and ask Walnut's AI how QLTY fits what you actually hold: what it overlaps with, what it leaves you exposed to, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What does GMO mean by quality?
+
Broadly, companies that earn high returns on the capital they employ, sustain those returns through competitive advantages that are hard to erode, and do not depend on heavy borrowing to achieve them. It is a judgement about business economics rather than about share price or growth rate. The manager assesses durability directly rather than inferring it from accounting ratios alone.
Is QLTY an index fund?
+
No. It is actively managed, with the portfolio constructed by GMO's investment team rather than replicating a published benchmark. There is no index whose composition the fund must match, and no reconstitution schedule dictating trades. That freedom is what produces a top ten worth roughly 46% of assets, a level of concentration few index products would allow.
Why is Lam Research the largest holding?
+
At 6.4% it ranks above Microsoft and Alphabet. Semiconductor capital equipment is an unusually concentrated industry where a few suppliers provide tools chipmakers have limited ability to replace, which produces high and persistent returns on capital. That profile fits the quality definition well. KLA at 4.7% is in the fund for the same reason, bringing the pair to 11.1% of assets.
How concentrated is QLTY?
+
The ten largest positions are around 46% of the fund, with the largest at 6.4%. For a strategy categorised as large blend, that is a high level of concentration. It means individual company developments move the fund noticeably, and it means results will separate from the broad market for long stretches. The concentration is deliberate, not a consequence of drift.
How does QLTY differ from a quality factor ETF?
+
Factor ETFs such as QUAL apply a mechanical screen, usually combining return on equity, debt levels and earnings stability, across a wide portfolio of holdings, and charge accordingly. QLTY is a concentrated portfolio built by an investment team making case-by-case judgements about business durability. The philosophies overlap, but one is a rules-based screen at low cost and the other is active management at a higher fee.
Why is healthcare 23% of the fund?
+
Because pharmaceutical and medical products companies often display the characteristics the strategy looks for: high returns on capital protected by patents, regulatory barriers, brand strength and distribution scale. Johnson and Johnson at 4.4% is the anchor position. That weighting is well above what a broad US market index carries, and it reflects the manager's assessment rather than any sector target.
How long has QLTY existed?
+
The ETF launched in 2023, giving it a short record. GMO has applied quality-focused equity investing in other vehicles for considerably longer, so the approach is not new even though this fund is. What has not been observed is how this particular portfolio, concentrated in technology and healthcare, behaves through a full market cycle including a sustained downturn.
What is the argument against paying 0.50%?
+
That it is roughly ten times what a broad US equity index fund costs and several times what a rules-based quality screen costs, and the manager must add that much value every year simply to draw level. Fee differences of this size compound. The counterargument is that a mechanical screen and a concentrated judgement-driven portfolio are genuinely different products, and only one of them requires paying for judgement.
What is QLTY's expense ratio?
+
QLTY has an expense ratio of 0.50% per year as of August 2026, charged by GMO and deducted from the fund's value rather than billed to you separately. On a $10,000 position that is roughly $50 a year. Fees compound over time, so on a long-term holding the expense ratio is one of the few return drivers you control. It is worth comparing against other funds that track Actively managed, no tracked index before you choose.
How do I compare QLTY to similar ETFs?
+
Put a few fields side by side: the expense ratio (fees compound over decades), the index or strategy it tracks, the top holdings and how much they overlap with what you already own, the dividend yield, and the AUM, liquidity, and bid-ask spread that affect trading costs. For index funds, tracking error (how closely it follows its index) and tax efficiency matter too. QLTY's figures are above; the full method is in Walnut's guide on how to compare ETFs.
Related ETFs
Walnut is informational, not investment advice. Holdings weights and fund statistics on this page are approximations stamped to August 2026; verify current figures against GMO's fund page or your broker before investing.